CGC
Price
$0.62
Change
+$0.06 (+10.71%)
Updated
Dec 1, 6:59 PM EST
73 days until earnings call
CYTH
Price
$1.47
Change
+$0.03 (+2.08%)
Updated
Dec 1, 6:59 PM EST
98 days until earnings call
Ad is loading...

Compare trend and price CGC vs CYTH

Header iconCGC vs CYTH Comparison
Open Charts CGC vs CYTHBanner chart's image
Canopy Growth
Price$0.62
Change+$0.06 (+10.71%)
Volume$20.45M
CapitalizationN/A
Cyclo Therapeutics
Price$1.47
Change+$0.03 (+2.08%)
Volume$13.32K
CapitalizationN/A
View a ticker or compare two or three
CGC vs CYTH Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CGC vs. CYTH commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and CYTH is a StrongBuy.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (CGC: $0.62 vs. CYTH: $1.47)
Brand notoriety: CGC: Notable vs. CYTH: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CGC: 111% vs. CYTH: 40%
Market capitalization -- CGC: $450.02M vs. CYTH: $30.74M
CGC [@Pharmaceuticals: Other] is valued at $450.02M. CYTH’s [@Pharmaceuticals: Other] market capitalization is $30.74M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $82.08B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileCYTH’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • CYTH’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTH is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 4 TA indicator(s) are bullish while CYTH’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 4 bullish, 3 bearish.
  • CYTH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CGC is a better buy in the short-term than CYTH.

Price Growth

CGC (@Pharmaceuticals: Other) experienced а +10.73% price change this week, while CYTH (@Pharmaceuticals: Other) price change was +13.95% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.45%. For the same industry, the average monthly price growth was +39.13%, and the average quarterly price growth was -6.49%.

Reported Earning Dates

CGC is expected to report earnings on Feb 15, 2024.

CYTH is expected to report earnings on Mar 11, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+3.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for CGC with price predictions.
OPEN
A.I.dvisor published
a Summary for CYTH with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CGC($450M) has a higher market cap than CYTH($30.7M). CYTH YTD gains are higher at: 3.521 vs. CGC (-73.247). CYTH has higher annual earnings (EBITDA): -19.36M vs. CGC (-1B). CGC has more cash in the bank: 270M vs. CYTH (1.8M). CYTH has less debt than CGC: CYTH (45.2K) vs CGC (765M). CGC has higher revenues than CYTH: CGC (369M) vs CYTH (952K).
CGCCYTHCGC / CYTH
Capitalization450M30.7M1,466%
EBITDA-1B-19.36M5,183%
Gain YTD-73.2473.521-2,080%
P/E RatioN/AN/A-
Revenue369M952K38,761%
Total Cash270M1.8M14,983%
Total Debt765M45.2K1,692,478%
FUNDAMENTALS RATINGS
CGC vs CYTH: Fundamental Ratings
CGC
CYTH
OUTLOOK RATING
1..100
5016
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6140
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYTH's Valuation (64) in the null industry is in the same range as CGC (93) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

CYTH's Profit vs Risk Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

CGC's SMR Rating (98) in the Agricultural Commodities Or Milling industry is in the same range as CYTH (100) in the null industry. This means that CGC’s stock grew similarly to CYTH’s over the last 12 months.

CYTH's Price Growth Rating (40) in the null industry is in the same range as CGC (61) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

CYTH's P/E Growth Rating (100) in the null industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that CYTH’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCCYTH
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TERN5.220.77
+17.30%
Terns Pharmaceuticals
OMIC0.420.03
+6.43%
Singular Genomics Systems
SUM35.550.86
+2.48%
Summit Materials
BLTE42.120.05
+0.12%
Belite Bio
MRVL52.80-2.93
-5.26%
Marvell Technology

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
+10.36%
SNDL - CGC
77%
Closely correlated
+4.90%
ACB - CGC
70%
Closely correlated
+1.80%
TLRY - CGC
66%
Loosely correlated
+4.97%
CRON - CGC
58%
Loosely correlated
+3.96%
OGI - CGC
57%
Loosely correlated
+4.69%
More

CYTH and

Correlation & Price change

A.I.dvisor tells us that CYTH and ACB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYTH and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTH
1D Price
Change %
CYTH100%
+2.08%
ACB - CYTH
24%
Poorly correlated
+1.80%
RDHL - CYTH
24%
Poorly correlated
-17.00%
CGC - CYTH
22%
Poorly correlated
+10.36%
TEVA - CYTH
21%
Poorly correlated
-1.12%
PTPI - CYTH
21%
Poorly correlated
-8.13%
More